Error loading player: No playable sources found

Regulatory Perspectives on In-use Storage of Biologic Products: Phase Appropriate Microbial Challenge Studies

Date
September 9, 2020
Explore related products in the following collection:
Thumbnail for Midwest Regional Forum 2020
CLINICAL (AND BEYOND) IN-USE STABILITY STUDIES – CHALLENGES, CONSIDERATIONS AND CASE STUDIES

A review of the regulatory requirements and guidance recommendations to support storage conditions of reconstituted and/or diluted drug products during IND development and for BLA approval will be presented. Microbial challenge study design and data analysis will be discussed. Case studies will be presented to illustrate how the microbial challenge data support the label instructions for storage conditions.

Speaker

Speaker Image for Patricia Hughes
Patricia Hughes, CDER, FDA
CDER, FDA

Related Products

Thumbnail for Analytical Considerations for Low Dose DAI Studies
Analytical Considerations for Low Dose DAI Studies
Dosage Administration Instructions are required prior to clinical dosing throughout a product lifecycle…